ClinicalTrials.gov
public full text
Public Domain
Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients
In nonmetastatic local advanced breast cancer patients, we are going to investigate whether circulating tumor DNA (ctDNA) detection can reflect the tumor response to neoadjuvant chemotherapy (NCT) and detect minimal residual disease after surgery.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Exploratory Study of Molecular Characterization in Patients With Metastatic Germ Cell Tumours Refractory/Resistant to Platinum Treatment#876142
- Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.#452340
- DNA Analysis of Blood and Tissue from Patients with Lung Cancer#1088722
- Circulating Tumor Cells in Lung Cancer#1031132
- Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description#812181
Record · ID 1060141
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive